Serum estradiol should be monitored not only during the peri-menopausal period but also the post-menopausal period at the time of aromatase inhibitor administration

被引:0
|
作者
Taeko Nagao
Misako Kira
Masako Takahashi
Junko Honda
Toshiyuki Hirose
Akira Tangoku
Hitoshi Zembutsu
Yusuke Nakamura
Mitsunori Sasa
机构
[1] The University of Tokushima,Department of Oncological and Regenerative Surgery, Institute of Health Biosciences
[2] Tokushima Breast Care Clinic,Department of Surgery
[3] National Higashi Tokushima Hospital,Department of Surgery
[4] The University of Tokyo,Human Genome Center, Institute of Medical Science
来源
World Journal of Surgical Oncology | / 7卷
关键词
Luteinizing Hormone; Aromatase Inhibitor; Anastrozole; Postmenopausal Breast Cancer; Epithelial Growth Factor Receptor;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 1 条
  • [1] Serum estradiol should be monitored not only during the peri-menopausal period but also the post-menopausal period at the time of aromatase inhibitor administration
    Nagao, Taeko
    Kira, Misako
    Takahashi, Masako
    Honda, Junko
    Hirose, Toshiyuki
    Tangoku, Akira
    Zembutsu, Hitoshi
    Nakamura, Yusuke
    Sasa, Mitsunori
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2009, 7